The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

Biodesix (NASDAQ:BDSX) is focused on developing diagnostic tests intended to improve patient outcomes by answering specific ...

It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...

Biodesix (NASDAQ:BDSX) outlined its current commercial focus, growth priorities, and financial milestones during a ...

Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...

As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If someone is concerned about lung cancer, what symptoms should they watch ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

With lung cancer the leading cause of cancer death both in the UK and globally, the UK's National Health Service (NHS) has launched a trial of AI lung scan analysis and robot-guided biopsies in an ...

Also, Medtech Global has integrated a clinical documentation AI into its popular patient management system in New Zealand.

Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received ...

Inside a mobile lab, Our Lady of the Lake Regional Medical Center is showcasing the robotic technology its surgeons and doctors are using to detect and treat lung cancer.